Karyopharm Therapeutics
	Developer of drugs for the treatment of cancer, inflammation and diseases related to cell proliferation. The company focuses on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.
	['', 'cancer treatment', ' ', 'inflammation drug', ' ', 'cell proliferation', '']
Matrix Therapeutics
	Developer of drugs for the treatment of cancer and inflammatory diseases. The company\'s product TO2 is a natural non-opioid compound combining anesthetic and analgesic activity, but without causing respiratory depression or lowering blood pressure. The company is a spin out from The University of Manchester.
	['', 'inflammatory diseases', ' ', 'cancer drugs', ' ', 'non-opioid compound', ' ', 'drug research', '']
IOmet Pharma
	Developer of drugs in the preclinical area of the drug discovery process. The company focuses on the development of innovative medicines for the treatment of cancer, with particular emphasis on the fields of cancer immunotherapy and cancer metabolism.
	['', 'drug discovery', ' ', 'nervous system disorder', ' ', 'oncology therapeutic', '']
Cabrellis Pharmaceuticals
	Developer of therapies for the treatment of cancer. The company\'s product includes synthetic anthracycline drug for small cell and nonsmall cell lung cancers in Japan. It also has drug commercialization rights in North America and Europe.
	['', 'cancer treatment', ' ', 'lung cancer treatment', ' ', 'drug commercialization', '']
KuDOS Pharmaceuticals
	Developer of oncology drugs. The company develops drugs for combination with chemo- and radiotherapy, based on expertise in DNA repair mechanisms for treatment of cancer.
	['', 'cancer treatment', ' ', 'drug discovery', ' ', 'drug delivery', '']
Ipsen Bioinnovation
	Provider of  biologics platform generating a pipeline of Targeted Secretion Inhibitors (TSIs) to treat diseases where secretion is the major driver, including pain, endocrine conditions and cancer. The company genetically engineers bacterial toxins to develop novel drugs that inhibit abnormal cell secretion, a key component of many diseases. The company is focused on the treatment of neurological, inflammatory and endocrine diseases.
	['', 'genetical engineering', ' ', 'abnormal cell secretion', ' ', 'Developer of drug', '']
Carolus Therapeutics
	Developer of biopharmaceuticals aimed at treating acute and chronic inflammation. The company develops new drugs that are aimed to provide relief to patients suffering from a host of disorders triggered by acute and chronic inflammation.
	['', 'chronic inflammation', ' ', 'inflammation diseases', ' ', 'noninvasively monitor', ' ', 'organ transplantation', '']
